25OH Vitamin D Total Assay - University of California, San Francisco
25OH Vitamin D Total Assay - University of California, San Francisco
25OH Vitamin D Total Assay - University of California, San Francisco
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
UNIVERSITY OF CALIFORNIA SAN FRANCISCO, CLINICAL LABORATORIES<br />
6. LIAISON 25 OH VITAMIN D TOTAL SPECIMEN DILUENT is stored at 2 – 8˚C upon receipt.<br />
When stored and handled as directed, the reagent is stable until the expiration date.<br />
7. LIAISON 25 OH VITAMIN D TOTAL CALIBRATION VERIFIERS are stored at 2 – 8˚C upon<br />
receipt. When stored and handled as directed, the reagent is stable until the expiration date.<br />
Once the vials are opened, the reagents are stable for 4 weeks when properly stored.<br />
INDICATIONS OF REAGENT DETERIORATION<br />
When a control value is out <strong>of</strong> the specified range, it may indicate deterioration <strong>of</strong> the reagents or<br />
errors in technique. Associated test results are invalid and samples must be retested. <strong>Assay</strong><br />
recalibration may be necessary.<br />
VI. WARNINGS AND PRECAUTIONS<br />
CAUTION<br />
For In Vitro Diagnostic Use.<br />
1. This product requires the handling <strong>of</strong> human specimens. It is recommended that all human<br />
sourced materials be considered potentially infectious and be handled in accordance with the<br />
OSHA Standard on Bloodborne Pathogens. Biosafety Level 2 or other appropriate biosafety<br />
practices should be used for materials.<br />
2. Some reagents used in this assay contain human source material and should be treated as<br />
potentially infectious. Each unit used in the preparation <strong>of</strong> this product has been tested by an<br />
FDA-approved method and found non-reactive for the presence <strong>of</strong> HBsAg, antibody to HCV and<br />
antibody to HIV1/2. While these methods are highly accurate, they do not guarantee that all<br />
infected units will be detected. This product may also contain other human source material for<br />
which there is no approved test. Because no known test method can <strong>of</strong>fer complete assurance<br />
that hepatitis B virus, hepatitis C virus (HCV), Human Immunodeficiency Virus (HIV) or other<br />
infectious agents are absent, all products containing human source material should be handled in<br />
accordance with good laboratory practices using appropriate precautions as described in the<br />
Centers for Disease Control and Prevention / National Institutes <strong>of</strong> Health Manual, “Biosafety in<br />
Microbiological and Biomedical Laboratories.” 4th ed., May 1999.<br />
3. Some reagents contain sodium azide as a preservative. Because sodium azide may form<br />
explosive lead azide or copper azide in plumbing, it is recommended that drains be thoroughly<br />
flushed with water after disposal <strong>of</strong> solutions containing sodium azide.<br />
4. For a detailed discussion <strong>of</strong> safety precautions during system operation, refer to the LIAISON<br />
User Manual.<br />
HANDLING PRECAUTIONS<br />
Do not use reagent kits beyond the expiration date.<br />
1. Contents <strong>of</strong> starter reagent bottles should never be pooled when replacing new containers with<br />
those in use, regardless <strong>of</strong> lot number.<br />
2. Before placing an integral on the instrument, suspend the magnetic particles in the first<br />
compartment by placing the integral in the Xcelerator for 30 seconds, then rotate the<br />
compartment for an additional minute. Check that all particles have been resuspended. Place<br />
the integral into the reagent bay and allow the instrument mixing to proceed for at least 30<br />
minutes prior to starting a test run.<br />
eterr:Library:Mail Downloads:<strong>25OH</strong>VitD<strong>Total</strong>.doc Page 6 <strong>of</strong> 15